Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EQUINE THYMOCYTE IMMUNE GLOBULIN for Bone marrow failure: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 57 adverse event reports in the FDA FAERS database where EQUINE THYMOCYTE IMMUNE GLOBULIN was used for Bone marrow failure.

Most Reported Side Effects for EQUINE THYMOCYTE IMMUNE GLOBULIN

Side Effect Reports % Deaths Hosp.
Transplant rejection 100 13.1% 1 1
Alopecia 98 12.8% 0 0
Acne 97 12.7% 0 0
Transplant dysfunction 97 12.7% 0 0
Ovarian cyst 96 12.6% 0 0
Drug ineffective 89 11.7% 23 19
Pyrexia 69 9.0% 14 33
Acute kidney injury 58 7.6% 9 24
Condition aggravated 55 7.2% 2 4
Product use in unapproved indication 55 7.2% 12 13
Off label use 54 7.1% 10 12
Pain 54 7.1% 4 5
Pneumonia 51 6.7% 1 3
Liver function test abnormal 48 6.3% 1 1
Hypertension 45 5.9% 7 16

Other Indications for EQUINE THYMOCYTE IMMUNE GLOBULIN

Aplastic anaemia (293) Product used for unknown indication (116) Immunosuppressant drug therapy (61) Transplant (57) Bone marrow conditioning regimen (36) Prophylaxis against graft versus host disease (25) Stem cell transplant (23) Prophylaxis against transplant rejection (22) Allogenic stem cell transplantation (10) Thrombocytopenia (10)

Other Drugs Used for Bone marrow failure

CYCLOSPORINE (110) ELTROMBOPAG OLAMINE (63) ELTROMBOPAG (52) FILGRASTIM (52) BUSULFAN (30) PEGFILGRASTIM (30) DEFERASIROX (26) FLUDARABINE (23) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (22) CYCLOPHOSPHAMIDE (19)

Related Pages

EQUINE THYMOCYTE IMMUNE GLOBULIN Full Profile All Bone marrow failure Drugs EQUINE THYMOCYTE IMMUNE GLOBULIN Demographics EQUINE THYMOCYTE IMMUNE GLOBULIN Timeline